221-222
Editorial
A Special Issue on channelopathies
Bernd Nilius
223-237
Ion Channels, Receptors and Transporters
Open AccessCardiac sodium channelopathies
Ahmad S. Amin, Alaleh Asghari-Roodsari and Hanno L. Tan
239-248
Invited Review
Open AccessSodium channelopathies of skeletal muscle result from gain or loss of function
Karin Jurkat-Rott, Boris Holzherr, Michael Fauler and Frank Lehmann-Horn
249-263
Ion Channels, Receptors and Transporters
Sodium channelopathies and pain
Angelika Lampert, Andrias O. O’Reilly, Peter Reeh and Andreas Leffler
265-276
Ion Channels, Receptors and Transporters
HERG1 channelopathies
Michael C. Sanguinetti
277-288
Ion Channels, Receptors and Transporters
KV7 channelopathies
Snezana Maljevic, Thomas V. Wuttke, Guiscard Seebohm and Holger Lerche
289-294
Invited Review
Kir 2.1 channelopathies: the Andersen–Tawil syndrome
Martin Tristani-Firouzi and Susan P. Etheridge
295-306
Ion Channels, Receptors and Transporters
Open AccessHuman KATP channelopathies: diseases of metabolic homeostasis
Timothy M. Olson and Andre Terzic
307-320
Integrative Physiology
KATP channelopathies in the pancreas
Maria S. Remedi and Joseph C. Koster
321-341
Invited Review
Channelopathies linked to plasma membrane phosphoinositides
Diomedes E. Logothetis, Vasileios I. Petrou, Scott K. Adney and Rahul Mahajan
343-351
Ion Channels, Receptors and Transporters
Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease
Ralf Köhler
353-359
Ion Channels, Receptors and Transporters
CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency
Ping Liao and Tuck Wah Soong
361-374
Ion Channels, Receptors and Transporters
Open AccessChannelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels
Jörg Striessnig, Hanno Jörn Bolz and Alexandra Koschak
375-393
Invited Review
CaV2.1 channelopathies
Daniela Pietrobon
395-403
Neuroscience
Role of voltage-gated calcium channels in epilepsy
Gerald W. Zamponi, Philippe Lory and Edward Perez-Reyes
405-415
Invited Review
HCN-related channelopathies
Mirko Baruscotti, Georgia Bottelli, Raffaella Milanesi, Jacopo C. DiFrancesco and Dario DiFrancesco
417-435
Ion Channels, Receptors and Transporters
CRAC channelopathies
Stefan Feske
437-450
Molecular and Genomic Physiology
Transient receptor potential channelopathies
Bernd Nilius and Grzegorz Owsianik
451-466
Signaling and Cell Physiology
Gap junctions in inherited human disease
Georg Zoidl and Rolf Dermietzel
467-480
Invited Review
Ryanodine receptor channelopathies
Matthew J. Betzenhauser and Andrew R. Marks
481-494
Invited Review
Inositol trisphosphate receptor Ca2+ release channels in neurological diseases
J. Kevin Foskett
495-503
Ion Channels and Transporters
Nicotinic receptor channelopathies and epilepsy
Ortrud K. Steinlein and Daniel Bertrand
505-523
Invited Review
Mutations affecting GABAergic signaling in seizures and epilepsy
Aristea S. Galanopoulou
525-542
Invited Review
Glutamate receptors, neurotoxicity and neurodegeneration
Anthony Lau and Michael Tymianski
543-557
Ion Channels, Receptors and Transporters
ClC transporters: discoveries and challenges in defining the mechanisms underlying function and regulation of ClC-5
Leigh Wellhauser, Christina D’Antonio and Christine E. Bear
559-569
Invited Review
Bestrophins and retinopathies
Qinghuan Xiao, H. Criss Hartzell and Kuai Yu